Hung N Luu, MD, PhD

Assistant Professor, Epidemiology


UPMC Cancer Pavilion, 5150 Centre Avenue-Suite 4C, Room 466, Pittsburgh, PA 15232
R-znvy: yhhu@hczp.rqh
Primary Phone: 967-178-8831
Fax: 967-178-8858

Personal Statement

Dr. Luu has a broad background in medicine and epidemiology, with specific training and expertise in the molecular and genetic epidemiology of cancer as well as large population-based studies. His main research focuses on etiological role of genetic factors, lifestyle factors, and environment exposures, particularly chronic inflammation, in the development of cancer as well as their impact on prognosis of cancer patients. His current cancer outcomes include GI tract cancers (i.e., colorectal cancer, pancreatic cancer and liver cancer). Other research interests include biomarkers identification for diagnostic and prognostic of cancer; host-virus/bacteria interaction in carcinogenesis; and gene-environmental and gene-gene interaction in cancer. Dr. Luu has extensive experience working with large prospective cohort studies such as the Southern Community Cohort Study-SCCS, the Shanghai Men’s Health Study-SMHS, and the Shanghai Women’s Health Study-SWHS. At the University of Pittsburgh, Dr. Luu has actively involved into two large prospective cohort studies: 1) the Shanghai Chinese Health Study (SCHS) and 2) the Shanghai Cohort Study (SCS). He is also an active member of several cancer consortium such as the Asia Cohort Consortium (ACC), the Stomach cancer Pooling Project-SToP Consortium and a founding member of the International Liver Cancer Epidemiology Consortium (ILCEC).


2015 | Vanderbilt University | Post-doctoral Fellow

2013 | Baylor College of Medicine | Post-doctoral Associate

2011 | University of Texas Health Science Center-Houston | PhD, Epidemiology

2003 | Tulane University | MPH, International Health/Health Economics

1997 | Thai Binh Medical University | MD, Medicine


EPI2171: Cancer Epidemiology

Selected Publications

Luu HN, Qi D, Wen W, Xiang YB, Cai Q, Li H, Yang G, Gao YT, Zheng W, Shu X. Are Dietary Antioxidant Intake Indices Correlated to Oxidative Stress and Inflammatory Marker Levels? Antioxid Redox Signal 2015;22(11):951-959 (PMID: 25602689 – PMCID: PMC4376488).

Luu HN, Blot WJ, Xiang YB, Cai H, Hargreaves MK, Li H, Yang G, Signorello L, Gao YT, Zheng W, Shu X. Association between nut consumption with total and cause-specific mortality: Evidence from three cohort studies of multi-ethnic populations. JAMA Intern Med 2015;175(5):755-766 (PMID: 25730101 - PMCID: PMC4474488).

Ren HG, Luu HN, Cai H, Xiang YB, Steinwandel M, Gao YT, Hargreaves MK, Zheng W, Blot WJ, Long JR, Shu X. Oral health and risk of colorectal cancer: results from three cohort studies and a meta-analysis. Ann Oncol 2016;27(7):1329-1336 (PMID: 27217540 -  PMCID: PMC4922320).

Beeghly-Fadiel*, Luu HN*, Du L, Parikh AA, McGavic DP, Raskin L. Clinical characteristics and survival association of early onset pancreatic cancer. Int J Cancer 2016;2169-2177 (PMID: 27416564-PMCID: not yet available) (*Co-first authors).

Luu HN, Long JR, Zheng Y, Cai Q, Gao YT, Zheng W, Shu X. Association of genetic risk score for shorter telomere length and risk of breast cancer. Cancer Causes Control 2016;DOI:10.1007/s10552-016-0798-z (PMID: 27581250-PMCID: PMC5061576).

Luu HN, Lin HY, Sørensen K, Ogunwobi OO, Kumar N, Chornokur G, Phelan CM, Jones D, Kidd LC, Batra J, Yamoah K, Berglund A, Rounbehler RJ,  Yang M, Lee SH, Kang N, Kim SJ, Park JY, Pietro GD. miRNAs associated with Prostate Cancer risk and progression. BMC Urol. 2017;17(18):DOI 10.1186/s12894-017-0206-6 (PMID: 28320379 – PMCID: PMC5359825). 

Luu HN, Qi M, Wang R, Adams-Haduch J, Miljkovic I, Opresko PL, Koh WP, Yuan JM. Association between leukocyte telomere length and the risk of colorectal cancer in the Singapore Chinese Health Study during 1993-2015. Clin Transl Gastroenterol. 2019;10(5):1-9 (PMID: 3117113 – PMCID: PMC6602767)

Luu HN, Huang JY, Wang R, Adams-Haduch J, Jin A, Koh WP, Yuan JM. Association between leukocyte telomere length and the risk of pancreatic cancer: Findings from the Singapore Chinese Health Study during 1993-2015. PLOS One 2019;14(8):e0221697. doi: 10.1371/journal.pone.0221697. 

Huang JY, Luu HN, Butler LM, Midttun Ø, Ulvik a, Wang R, Jin A, Gao YT, Tan Y, Ueland PM, Koh WP, Yuan J-M. A prospective evaluation of serum choline metabolites in relation to pancreatic cancer risk in two prospective cohort studies. Int J Cancer 2020;March 29: (PMID: 32222976)

Thomas CE, Luu HN, Wang R, Adams-Haduch J, Jin A, Koh WP, Yuan JM. Association between dietary tomato intake and the risk of hepatocellular carcinoma: Findings from a prospective study Cancer Epidemiol Biomarkers Prev. 2020; April 13;doi: 10.1158/1055-9965.EPI-20-0051 (PMID: 3225431)

Hung N Luu